Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia

BMC Infectious Diseases

Volumn 10, Issue , 2010, Pages

  Uusküla, Anneli ^a   Kals, Mart ^a   Kosenkranius, Liina ^b   McNutt, Louise Anne ^c   DeHovitz J, Jack ^d  

^a UNIVERSITY OF TARTU   (Estonia)

^b Quattromed HTI Laborid   (Estonia)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT; DNA DETERMINATION; ESTONIA; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 21; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 66; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; VAGINA SMEAR; VIRUS DETECTION; VIRUS INFECTION; WART VIRUS; ADOLESCENT; CLASSIFICATION; GENETICS; GENOTYPE; ISOLATION AND PURIFICATION; METHODOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; RISK FACTOR; SELF EXAMINATION; VAGINA; VIROLOGY;

ADOLESCENT; ADULT; DNA, VIRAL; ESTONIA; FEMALE; GENOTYPE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RISK FACTORS; SELF-EXAMINATION; VAGINA; YOUNG ADULT;

EID: 77949458587     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-10-63     Document Type: Article

References (36)

1. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997, 102:3-8. 10.1016/S0002-9343(97)00177-0, 9217656.
2. Clifford GM, Smith JS, Aguardo T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003, 89:101-105. 10.1038/sj.bjc.6601024, 2394204, 12838308.
3. Anonymous European Medicines Agency, EPARs for authorised medicinal products for human use. (http://www.emea.europa.eu/humandocs/Humans/EPAR/gardasil/gardasil.htm, http://www.emea.europa.eu/humandocs/Humans/EPAR/cervarix/cervarix.htm, accessed 29.09.2008), Anonymous.
4. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE. Prevalence of HPV Infection Among Females in the United States. JAMA 2007, 297(8):813-819. 10.1001/jama.297.8.813, 17327523.
5. Arbyn M, Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J Clin Virol 2007, 38(3):189-97. 10.1016/j.jcv.2006.12.009, 17258503.
6. Haug CJ. Human Papillomavirus Vaccination -- Reasons for Caution. N Engl J Med 2008, 359:861-862. 10.1056/NEJMe0804638, 18716305.
7. Shah KV, Daniel RW, Tennant MK, Shah N, McKee JKT, Rompalo A. Diagnosis of human papillomavirus infection by dry vaginal swabs in military women. Sex Transmit Infect 2001, 77:260-264.
8. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, Tu W, Juliar BE, Breen TE, Fortenberry JD. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 2005, 191(2):182-92. 10.1086/426867, 2586143, 15609227.
9. Masek BJ, Arora N, Quinn N, Aumakhan B, Holden J, Hardick A, Agreda P, Barnes M, Gaydos CA. Performance of three nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae by use of self-collected vaginal swabs obtained via an Internet-based screening program. J Clin Microbiol 2009, 47(6):1663-7. 10.1128/JCM.02387-08, 2691063, 19386838.
10. Gaydos CA, Rompalo AM. The Use of Urine and Self-obtained Vaginal Swabs for the Diagnosis of Sexually Transmitted Diseases. Curr Infect Dis Rep 2002, 4(2):148-157. 10.1007/s11908-002-0057-4, 11927048.
11. Uusküla A, Kals M, Denks K, Nurm U, Kasesalu L, Dehovitz J, McNutt LA. The prevalence of chlamydial infection in Estonia: a population-based survey. Int J STD AIDS 2008, 19(7):455-8. 10.1258/ijsa.2008.007325, 18574116.
12. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985, 230:1350-4. 10.1126/science.2999980, 2999980.
13. Gravitt PE, Peyton CL, Alessi TQ, Wheeler CM, Coutlée F, Hildesheim A, Schiffman MH, Scott DR, Apple RJ. Improved Amplification of Genital Human Papillomaviruses. J Clin Microbiol 2000, 38(1):357-61. 88724, 10618116.
14. Meyer T, Arndt R, Stockfleth E, Flammann HT, Wolf H, Reischl U. Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. Biotechniques 1995, 19(4):632-9.
15. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24(S3):S1-S10. 10.1016/j.vaccine.2006.05.115, 16406226.
16. Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. International Journal of Epidemiology 1997, 26(1):224-227. 10.1093/ije/26.1.224, 9126524.
17. Anonymous Human Papillomavirus and Cervical Cancer. Summary Report 2007. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre) accessed 10.09.2008, Anonymous., http://www.who.int/hpvcentre/statistics/dynamic/ico/country_pdf/XEX.pdf?CFID=1179971&CFTOKEN=54301985
18. Goldie SJ, Goldhaber-Fiebert JD, Garnett GP. Chapter 18: Public health policy for cervical cancer prevention: The role of decision science, economic evaluation, and mathematical modeling. Vaccine 2006, 24(Suppl 3):S155-63.
19. Leinonen M, Kotaniemi-Talonen L, Anttila A, Dyba T, Tarkkanen J, Nieminen P. Prevalence of oncogenic human papillomavirus infection in an organised screening population in Finland. Int J Cancer 2008, 123(6):1344-9. 10.1002/ijc.23670, 18566992.
20. Kjær SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008, 123(8):1864-1870. 10.1002/ijc.23712, 18661520.
21. Skjeldestad FE, Mehta V, Sings HL, Øvreness T, Turpin J, Su L, Boerckel P, Roberts C, Bryan J, Jansen KU, Esser MT, Liaw KL. Seroprevalence and genital DNA prevalence of HPV types 6, 11, 16 and 18 in a cohort of young Norwegian women: study design and cohort characteristics. Acta Obstet Gynecol Scand 2008, 87(1):81-8. 10.1080/00016340701714703, 17943470.
22. Coupe VMH, Berkhof J, Bulkmans NWJ, Snijders PJF, Meijer CJLM. Age-dependent prevalence of 14 high-risk HPV types in the Netherlands: implications for prophylactic vaccination and screening. Br J Cancer 2008, 98:646-651. 10.1038/sj.bjc.6604162, 2243156, 18182990.
23. Sargent A, Bailey A, Almonte M, Turner A, Thomson C, Peto J, Desai M, Mather J, Moss S, Roberts C, Kitchener HC, . ARTISTIC Study Group Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial. Br J Cancer 2008, 98(10):1704-9. 10.1038/sj.bjc.6604324, 2391119, 18392052, ARTISTIC Study Group.
24. Petignat P, Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 2007, 105(2):530-5. 10.1016/j.ygyno.2007.01.023, 17335880.
25. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V. HPV Self-collection Guidelines Panel. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Can 2007, 29(10):817-28.
26. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006, 24(suppl 1):S1-S15.
27. Kreimer AR, Katki HA, Schiffman M, Wheeler CM, Castle PE, . ASCUS-LSIL Triage Study Group Viral determinants of human papillomavirus persistence following loop electrical excision procedure treatment for cervical intraepithelial neoplasia grade 2 or 3. Cancer Epidemiol Biomarkers Prev 2007, 16(1):11-6. 10.1158/1055-9965.EPI-06-0710, 17220326, ASCUS-LSIL Triage Study Group.
28. Winer RL, Hughes JP, Feng Q, O'Reilly S, Kiviat NB, Koutsky LA. Comparison of Incident Cervical and Vulvar/Vaginal Human Papillomavirus Infections in Newly Sexually Active Young Women. J Infect Dis 2009, 199(6):815-8. 10.1086/597118, 19434913.
29. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD. A comparison of cervical and vaginal human papillomavirus. Sex Transm Dis 2007, 34(11):849-55. 10.1097/OLQ.0b013e318064c8c5, 17621246.
30. Kulmala SM, Shabalova IP, Petrovitchev N, Syrjänen KJ, Gyllensten UB, Syrjänen SM, . NIS Study Group Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union. J Med Virol 2007, 79(6):771-81. 10.1002/jmv.20839, 17457909, NIS Study Group.
31. Butsch Kovacic M, Castle PE, Herrero R, Schiffman M, Sherman ME, Wacholder S, Rodriguez AC, Hutchinson ML, Bratti MC, Hildesheim A, Morales J, Alfaro M, Burk RD. Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality. Cancer Res 2006, 66(20):10112-9. 10.1158/0008-5472.CAN-06-1812, 17047075.
32. Moscicki AB, Widdice L, Ma Y, Farhat S, Miller-Benningfield S, Jonte J, Jay J, Goodwin-Demedina C, Hanson E, Clayton L, Shiboski S. Comparison of natural histories of human papillomavirus (HPV) detected by clinician- and self-sampling. Int J Cancer 2010,
33. Shikary T, Bernstein DI, Jin Y, Zimet GD, Rosenthal SL, Kahn JA. Epidemiology and risk factors for human papillomavirus infection in a diverse sample of low-income young women. J Clin Virol 2009, 46(2):107-11. 10.1016/j.jcv.2009.07.006, 19665924.
34. Velicer C, Zhu X, Vuocolo S, Liaw KL, Saah A. Prevalence and incidence of HPV genital infection in women. Sex Transm Dis 2009, 36(11):696-703. 10.1097/OLQ.0b013e3181ad25ff, 19652630.
35. Silins I, Wang X, Tadesse A, Jansen KU, Schiller JT, Avall-Lundqvist E, Frankendal B, Dillner J. A population-based study of cervical carcinoma and HPV infection in Latvia. Gynecol Oncol 2004, 93(2):484-92. 10.1016/j.ygyno.2004.01.044, 15099967.
36. Aleksandrova IN, Lyshchëv AA, Safronnikova NR, Rudenko VI, Imianitov EN, Khnason KP. Papillomavirus infection in healthy women from St. Petersburg. Vopr Onkol 2000, 46(2):175-9.